Phytochemicals With Anti 5-Alpha-Reductase Activity: A Prospective For Prostate Cancer Treatment
July 2021
in “
F1000Research
”
TLDR Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.
The document "Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment" explores the potential of plant-derived chemicals, or phytochemicals, in treating prostate cancer. The study focuses on the enzyme 5-alpha-reductase (5αR), which converts testosterone into dihydrotestosterone (DHT), a hormone that can stimulate prostate cancer growth. Phytochemicals such as phytosterols, polyphenols, and fatty acids have been shown to inhibit this enzyme, reducing DHT levels and potentially slowing or stopping the growth of prostate cancer. Various phytochemicals were found to inhibit tumor cell migration, invasion, and proliferation, and promote cell apoptosis in different cell lines and animal models. The document concludes that these phytochemicals could be promising candidates for alternative prostate cancer treatment approaches.